Search

Your search keyword '"Hammerschmidt, R."' showing total 371 results
Start Over Author "Hammerschmidt, R."
371 results on '"Hammerschmidt, R."'

2. Solutions to the Armillaria root rot affecting the US stone fruit industry

Author

Gasic, K., primary, Adelberg, J., additional, Baumgartner, K., additional, Brannen, P.M., additional, Cai, L., additional, Calle, A., additional, Chavez, D., additional, Devkota, P., additional, Gradziel, T.M., additional, Hammerschmidt, R., additional, Iezzoni, A., additional, Koc, B., additional, Mark, T., additional, Melgar, J.C., additional, Reighard, G.L., additional, Saski, C., additional, Schnabel, G., additional, Tharayil, N., additional, and Vassalos, M., additional

Published
2022
Full Text
View/download PDF

3. SALUS—a non-inferiority trial to compare self-tonometry in glaucoma patients with regular inpatient intraocular pressure controls: study design and set-up.

Author

Oldiges, Kristina, Steinmann, Maren, Duevel, Juliane Andrea, Gruhn, Sebastian, Diener, Raphael, Leclaire, Martin Dominik, Al-Nawaiseh, Sami, Eter, Nicole, on behalf of the SALUS study group, Greiner, W., Behm, B., Kisielinski, D., Schwarze, K., Meyer, F., Warkentin, S., Hammerschmidt, R., Luzius, M., Berlage, T., Becker, M., and Charles, A.

Subjects
INTRAOCULAR pressure, PRESSURE control, GLAUCOMA, EXPERIMENTAL design, HEALTH literacy, CLINICAL trials monitoring
Abstract

Purpose: The SALUS study aims to improve the healthcare situation for glaucoma patients in Germany. In order to detect diurnal intraocular pressure (IOP) fluctuations, inpatient monitoring of IOP in an eye hospital for a minimum of 24 h is the current standard. SALUS assesses the benefits of a new form of outpatient care, where IOP can be measured by the patients themselves at home using a self-tonometer. This approach should promote the patient's health competence and empowerment within the healthcare system while reducing treatment costs. Methods: The SALUS study is a randomized controlled, open non-inferiority trial, alongside an economic analysis, determining whether outpatient monitoring of IOP with self-tonometry is at least as effective as current standard care and would reduce treatment costs. Participants (n = 1980) will be recruited by local ophthalmologists in the area of Westphalia-Lippe, Germany, and randomized to receive 7-day outpatient or 24-h inpatient monitoring. Participants in both study arms will also receive 24-h blood pressure monitoring. Furthermore, patient data from both study groups will be collected in an electronic case file (ECF), accessible to practitioners, hospitals, and the study participants. The primary endpoint is the percentage of patients with IOP peaks, defined as levels 30% above the patient-specific target pressure. Data will also be collected during initial and final examinations, and at 3, 6, and 9 months after the initial examination. Results: The study implementation and trial management are represented below. Conclusion: SALUS is a pioneering prospective clinical trial focused on the care of glaucoma patients in Germany. If SALUS is successful, it could improve the healthcare situation and health literacy of the patients through the introduction of various telemedical components. Furthermore, the approach would almost certainly reduce the treatment costs of glaucoma care. Trial registration: ClinicalTrials.gov ID: NCT04698876, registration date: 11/25/2020. DRKS-ID: DRKS00023676, registration date: 11/26/2020. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

37. Ueber die Bestimmung des Rendements und die chemische Analyse von Rohzucker

Author

Scheibler, C., Karcz, M., Strohmer, Fr., Stift, A., Holarek, Sostmann, E., Lach, J., von Lippmann, E. O., Herzfeld, A., Prinsen-Geerligs, H. C., Scheller, R., Bodenbender, H., Seyffart, J., Ladureau, A., Reichardt, H., Aulard, A., Courtonne, H., Hanause, H., Wiechmann, F. G., Sidersky, D., Biard, L., Stammer, K., Donath, Ed., Hattensaur, G., Lucien, J., de Grobert, J., Boyer, E., Grünhut, L., Alberti, R., Hempel, C., Eichleitner, Fr., Liesse, Ch., Pellet, H., Sachs, F., Gruselin, A., Delville, E., Gunning, J. W., Drenckmann, B., de Puydt, J., Josse, A., Herles, Fr., Degener, P., Sickel, R., Grzesinsky, R., Martina, G., Petzival, E., Moor, J. D., Josef, Fric, Jan, Baumann, J., Landolt, H., Rimbach, E., Casteels, O., Jungfleisch, E., Grimbert, L., Hammerschmidt, R., Deltour, Em., Preuss, E., Leplay, Winter, H., and Mehne, P.

Published
1896
Full Text
View/download PDF

42. Erfahrungen mit 79 Patienten

Author

Zipfel, B, Knollmann, F, Hammerschmidt, R, Krabatsch, T, and Hetzer, R

Subjects
ddc: 610
Published
2004

43. A Coordinated Effort to Manage Soybean Rust in North America: A Success Story in Soybean Disease Monitoring

Author

Sikora, E. J., primary, Allen, T. W., additional, Wise, K. A., additional, Bergstrom, G., additional, Bradley, C. A., additional, Bond, J., additional, Brown-Rytlewski, D., additional, Chilvers, M., additional, Damicone, J., additional, DeWolf, E., additional, Dorrance, A., additional, Dufault, N., additional, Esker, P., additional, Faske, T. R., additional, Giesler, L., additional, Goldberg, N., additional, Golod, J., additional, Gómez, I. R. G., additional, Grau, C., additional, Grybauskas, A., additional, Franc, G., additional, Hammerschmidt, R., additional, Hartman, G. L., additional, Henn, R. A., additional, Hershman, D., additional, Hollier, C., additional, Isakeit, T., additional, Isard, S., additional, Jacobsen, B., additional, Jardine, D., additional, Kemerait, R., additional, Koenning, S., additional, Langham, M., additional, Malvick, D., additional, Markell, S., additional, Marois, J. J., additional, Monfort, S., additional, Mueller, D., additional, Mueller, J., additional, Mulrooney, R., additional, Newman, M., additional, Osborne, L., additional, Padgett, G. B., additional, Ruden, B. E., additional, Rupe, J., additional, Schneider, R., additional, Schwartz, H., additional, Shaner, G., additional, Singh, S., additional, Stromberg, E., additional, Sweets, L., additional, Tenuta, A., additional, Vaiciunas, S., additional, Yang, X. B., additional, Young-Kelly, H., additional, and Zidek, J., additional

Published
2014
Full Text
View/download PDF

50. Inducing resistance: a summary of papers presented at the First International Symposium on Induced Resistance to Plant Diseases, Corfu, May 2000

Author

Hammerschmidt, R., Métraux, J.-P., and Loon, L.C. van

Subjects
fungi, food and beverages, Biologie
Abstract

The First International Symposium on Induced Resistance to Plant Diseases, organized by Eris Tjamos, brought together over 150 participants to discuss the complexities, questions and future direction of research on the mechanisms by which plants can become better able to defend themselves against pathogen attack. Although the term immunization has been used to denote treatments that enhance the defensive capacity of plants, the correspondence to vaccination in vertebrates is far-fetched: the induced state is by no means specific, but rather constitutes a more general increase in plant resistance to various types of pathogens. Moreover, it seldom prevents disease from occurring but generally reduces its extent or severity. These characteristics make induced resistance a powerful mechanism to exploit for enhancing the overall resistance in crop plants. Indeed, the first commercial chemical triggering induced resistance in plants, acibenzolar-Smethyl (BTH) was recently introduced on the market by Novartis under the tradenames Actigard (USA) and BION (Europe).

Published
2000

Catalog

Books, media, physical & digital resources
See catalog results